JSCN2022

Session information

Platform Session

[EO-01] Platform Session 01:Neuromuscular Disorders 1

Thu. Jun 2, 2022 10:50 AM - 11:50 AM Room 6 (Medium Conference Room 202)

Chair: Mohamed Ahmad Rithauddin(Women and Children Hospital Kuala Lumpul),Hirofumi Komaki(National Center of Neurology and Psychiatry)

Yoshihiko Saito1,2,Shinichiro Hayashi1,Satoru Noguchi1,Ichizo Nishino1 (1. Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan,2. Department of Child Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.2)

Hideyuki Iwayama1,Kohei Kawahara1,Mizuki Takagi1,Shingo Numoto1,2,Yoshiteru Azuma1,2,Hirokazu Kurahashi1,Yumiko Yasue2,Hiroyuki Kawajiri2,Atsushi Yanase2,Teruyoshi Ito2,Shinya Kimura2,Toshiyuki Kumagai3,4,Akihisa Okumura1 (1. Department of Pediatrics, Aichi Medical University, Nagakute, Japan,2. Center of rehabilitation, Aichi Medical University Hospital, Nagakute, Aichi, Japan,3. Department of Pediatric Neurology, Aichi Prefectural Colony Central Hospital, Kasugai, Aichi, Japan,4. Kuma Home Medical Care Clinic, Nagoya, Aichi, Japan.)

Yuko Motohashi1,2,Norio Motohashi2,Akihiko Ishiyama1,Eri Takeshita1,Yoshitsugu Aoki2,Hirofumi Komaki1,3,Masayuki Sasaki1 (1. Department of Child Neurology, National Center of Neurology and Psychiatry, Tokyo, Japan,2. Department of Molecular Therapy, National Center of Neurology and Psychiatry, Tokyo, Japan,3. Translational Medical Center, National Center of Neurology and Psychiatry, Tokyo, Japan)

Satomi Ohtaki1,Nozomi Ryuno1,Hiromi Teranishi1,Kaori Sassa1,Megumi Tsuruoka2,4,Sayaka Ajihara1,2,Eri Takeshita3,Yuko Akioka1,Akira Ohtake1,2,4,Hirofumi Komaki6,Hideo Yamanouchi1,5 (1. Departments of Pediatrics, Saitama Medical University, Saitama, Japan,2. Departments of Clinical Genomics, Saitama Medical University, Saitama, Japan,3. Department of Child Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan,4. Center for Intractable Diseases, Saitama Medical University Hospital, Saitama, Japan.,5. Comprehensive Epilepsy Center, Saitama Medical University Hospital, Saitama, Japan.,6. Translational Medical Center, National Center of Neurology and Psychiatry(NCNP))

Mariko Taniguchi—Ikeda1,Michiyo Koyanagi—Aoi2,5,Keiko Ishigaki3,Tatsushi Toda4,Takashi Aoi2,5 (1. Department of Clinical Genetics, Fujita Health University Hospital, Aichi, Japan,2. Kobe University Graduate School of Medicine, Department of iPS Cell Applications, Kobe, Hyogo, Japan,3. Department of Pediatrics, Tokyo Women's Medical University, School of Medicine, Tokyo, Japan,4. Department of Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan,5. Division of Advanced Medical Science, Graduate School of Science, Technology and Innovation, Kobe University, Hyogo, Japan)

Sassa Kaori1,5,Ohtaki Satomi1,5,Teranishi Hiromi1,5,Namba Akira2,3,5,Tsuruoka Megumi2,5,Kunikata Tetsuya4,Ohtake Akira1,2,6,Yamanouchi Hideo1,5 (1. Departments of Pediatrics, Saitama Medical University Hospital, Saitama, Japan,2. Clinical Genomics, Saitama Medical University Hospital, Saitama, Japan,3. Obstetrics and Gynecology, Saitama Medical University Hospital, Saitama, Japan,4. Neonatology, Saitama Medical University Hospital, Saitama, Japan,5. Comprehensive Epilepsy Center, Saitama Medical University Hospital, Saitama, Japan.,6. Center for Intractable Diseases, Saitama Medical University Hospital, Saitama, Japan.)